|
BET inhibitors act synergistically with PARP inhibitors
|
3
|
Zenith Epigenetics
|
Jul 27, 2017 10:27AM
|
|
Re: The CKD opportunity
|
5
|
Resverlogix Corp.
|
Jul 27, 2017 10:38AM
|
|
Re: Up isn't always good...and Down isn't always bad
|
6
|
Resverlogix Corp.
|
Jul 27, 2017 10:54AM
|
|
Re: The CKD opportunity
|
5
|
Resverlogix Corp.
|
Jul 27, 2017 11:16AM
|
|
Re: Debt and 28 August
|
3
|
Resverlogix Corp.
|
Jul 28, 2017 10:51AM
|
|
Re: Excellent Discussion
|
2
|
Resverlogix Corp.
|
Jul 28, 2017 10:59AM
|
|
Re: Debt and 28 August
|
2
|
Resverlogix Corp.
|
Jul 28, 2017 11:06AM
|
|
biOasis AGM re-scheduled for September 21, 2017
|
|
BIOASIS TECHNOLOGIES INC
|
Jul 28, 2017 11:17AM
|
|
Re: No answer yet on what the change in study protocol is....
|
4
|
Resverlogix Corp.
|
Jul 28, 2017 12:28PM
|
|
Re: No answer yet on what the change in study protocol is....
|
3
|
Resverlogix Corp.
|
Jul 28, 2017 01:24PM
|
|
DDF Summit: Drug Delivery & Formulation, August 28-29, 2017
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jul 28, 2017 01:54PM
|
|
Re: No answer yet on what the change in study protocol is....
|
4
|
Resverlogix Corp.
|
Jul 28, 2017 02:13PM
|
|
Re: No answer yet on what the change in study protocol is....
|
2
|
Resverlogix Corp.
|
Jul 28, 2017 02:54PM
|
|
Re: Apabetalone
|
4
|
Resverlogix Corp.
|
Jul 29, 2017 03:23PM
|
|
Re: Zenith new VP
|
3
|
Zenith Epigenetics
|
Jul 30, 2017 08:49AM
|
|
Re: I'm pretty sure this question has been covered....
|
3
|
Resverlogix Corp.
|
Jul 31, 2017 01:39PM
|
|
Re: I'm pretty sure this question has been covered....
|
3
|
Resverlogix Corp.
|
Jul 31, 2017 03:51PM
|
|
Re: I'm pretty sure this question has been covered....
|
4
|
Resverlogix Corp.
|
Jul 31, 2017 05:38PM
|
|
Re: I'm pretty sure this question has been covered....
|
3
|
Resverlogix Corp.
|
Aug 01, 2017 10:54AM
|
|
Re: Zenith new VP
|
1
|
Zenith Epigenetics
|
Aug 01, 2017 10:59AM
|
